Pharmena Spółka Akcyjna financials
Pharmena Spółka Akcyjna
Country: PL Reporting currency: PLN Latest annual report: 2022-12-31
LEI:
259400RHT936BBKW0955 Financial statements
(PLN, as reported — unscaled; 101 line items across 2 annual periods)
| Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Revenue | PLN 19.0M | PLN 15.2M |
| Cost of sales | PLN 8.7M | PLN 7.4M |
| Gross profit | PLN 10.3M | PLN 7.8M |
| Other income | PLN 13.0K | PLN 71.0K |
| Administrative expenses | PLN 3.2M | PLN 4.7M |
| Operating profit (EBIT) | -PLN 508.0K | -PLN 4.0M |
| Finance costs | PLN 904.0K | PLN 474.0K |
| Profit before tax | -PLN 1.4M | -PLN 4.5M |
| Income tax expense | PLN 204.0K | PLN 182.0K |
| Profit for the year | -PLN 1.6M | -PLN 4.6M |
| — attributable to owners | -PLN 1.6M | -PLN 4.6M |
| — attributable to NCI | -PLN 46.0K | -PLN 47.0K |
| Total comprehensive income | -PLN 1.7M | -PLN 4.8M |
| Per share | ||
| Basic EPS | PLN -0.14 | PLN -0.41 |
| Diluted EPS | PLN -0.14 | PLN -0.41 |
| Free cash flow / share | PLN 0.14 | PLN -0.31 |
| Cash flow statement | ||
| Cash generated from operations | PLN 2.0M | -PLN 3.2M |
| Net cash from operating activities | PLN 1.8M | -PLN 3.2M |
| Net cash from investing activities | -PLN 219.0K | -PLN 248.0K |
| Net cash from financing activities | -PLN 1.5M | PLN 3.2M |
| Proceeds from borrowings | PLN 0 | PLN 4.5M |
| Repayments of borrowings | PLN 370.0K | PLN 10.0K |
| Lease liability payments | PLN 284.0K | PLN 255.0K |
| Net change in cash | PLN 134.0K | -PLN 259.0K |
| Balance sheet | ||
| Total assets | PLN 12.6M | PLN 11.2M |
| Non-current assets | PLN 2.6M | PLN 3.0M |
| Property, plant & equipment | PLN 48.0K | PLN 40.0K |
| Current assets | PLN 10.0M | PLN 8.2M |
| Inventories | PLN 4.6M | PLN 3.5M |
| Trade & other receivables | PLN 3.8M | PLN 3.3M |
| Cash & equivalents | PLN 1.6M | PLN 1.5M |
| Total equity | -PLN 6.8M | -PLN 5.1M |
| — attributable to owners | -PLN 6.5M | -PLN 4.9M |
| Non-controlling interests | -PLN 302.0K | -PLN 256.0K |
| Non-current liabilities | PLN 2.4M | PLN 4.7M |
| Lease liabilities (non-current) | PLN 194.0K | PLN 490.0K |
| Current liabilities | PLN 17.0M | PLN 11.6M |
| Lease liabilities (current) | PLN 316.0K | PLN 292.0K |
| Trade & other payables | PLN 9.0M | PLN 6.4M |
| Derived metrics | ||
| Free cash flow | PLN 1.6M | -PLN 3.5M |
| Operating margin | -2.7% | -26.2% |
| Net margin | -8.5% | -30.5% |
| Return on equity | 23.8% | 90.6% |
| Cash conversion ratio | -1.13× | 0.70× |
| Capex coverage | 8.05× | -10.11× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -PLN 1.1M | PLN 535.0K |
| Adjustments For Decrease Increase In Trade and Other Receivables | -PLN 503.0K | -PLN 682.0K |
| Adjustments For Depreciation and Amortisation Expense | PLN 561.0K | PLN 626.0K |
| Adjustments For Increase Decrease In Trade and Other Payables | PLN 3.7M | PLN 612.0K |
| Adjustments For Interest Expense | PLN 625.0K | PLN 253.0K |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | PLN 162.0K | PLN 53.0K |
| Adjustments For Reconcile Profit Loss | PLN 3.4M | PLN 1.3M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -PLN 56.0K | -PLN 132.0K |
| Basic Earnings Loss Per Share From Continuing Operations | PLN -0.14 | PLN -0.41 |
| Basic Earnings Loss Per Share From Discontinued Operations | PLN 0.00 | PLN 0.00 |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | PLN 4.0K | PLN 0 |
| Changes In Equity | -PLN 1.7M | -PLN 4.8M |
| Comprehensive Income Attributable To Noncontrolling Interests | -PLN 46.0K | -PLN 47.0K |
| Comprehensive Income Attributable To Owners of Parent | -PLN 1.6M | -PLN 4.7M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | PLN 10.0M | PLN 8.2M |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | PLN 17.0M | PLN 11.6M |
| Current Provisions | PLN 5.0K | PLN 0 |
| Current Provisions For Employee Benefits | PLN 5.0K | PLN 0 |
| Current Tax Liabilities Current | PLN 174.0K | PLN 167.0K |
| Deferred Tax Assets | PLN 947.0K | PLN 978.0K |
| Diluted Earnings Loss Per Share From Continuing Operations | PLN -0.14 | PLN -0.41 |
| Diluted Earnings Loss Per Share From Discontinued Operations | PLN 0.00 | PLN 0.00 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -PLN 2.0K | -PLN 3.0K |
| Equity and Liabilities | PLN 12.6M | PLN 11.2M |
| Finance Income | PLN 0 | PLN 0 |
| Income Taxes Paid Refund Classified As Operating Activities | PLN 167.0K | PLN 39.0K |
| Increase Decrease In Cash and Cash Equivalents | PLN 132.0K | -PLN 262.0K |
| Increase Decrease Through Transfers and Other Changes Equity | PLN 0 | PLN 0 |
| Intangible Assets Other Than Goodwill | PLN 999.0K | PLN 966.0K |
| Interest Paid Classified As Financing Activities | PLN 624.0K | PLN 248.0K |
| Issued Capital | PLN 1.1M | PLN 1.1M |
| Liabilities | PLN 19.4M | PLN 16.3M |
| Noncurrent Provisions | PLN 61.0K | PLN 24.0K |
| Noncurrent Provisions For Employee Benefits | PLN 16.0K | PLN 24.0K |
| Noncurrent Receivables | PLN 165.0K | PLN 201.0K |
| Other Adjustments To Reconcile Profit Loss | PLN 7.0K | PLN 6.0K |
| Other Comprehensive Income | -PLN 55.0K | -PLN 134.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -PLN 61.0K | -PLN 141.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | PLN 6.0K | PLN 7.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -PLN 61.0K | -PLN 141.0K |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | PLN 6.0K | PLN 7.0K |
| Other Current Financial Liabilities | PLN 7.5M | PLN 4.7M |
| Other Expense By Function | PLN 314.0K | PLN 465.0K |
| Other Inflows Outflows of Cash Classified As Financing Activities | -PLN 188.0K | -PLN 823.0K |
| Other Longterm Provisions | PLN 45.0K | PLN 0 |
| Other Noncurrent Financial Liabilities | PLN 2.1M | PLN 4.2M |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | PLN 11.0K | PLN 71.0K |
| Profit Loss From Continuing Operations | -PLN 1.6M | -PLN 4.6M |
| Profit Loss From Discontinued Operations | PLN 0 | PLN 0 |
| Purchase of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | PLN 226.0K | PLN 319.0K |
| Reserve of Exchange Differences On Translation | PLN 145.0K | PLN 206.0K |
| Reserve of Remeasurements of Defined Benefit Plans | PLN 2.0K | -PLN 4.0K |
| Retained Earnings | -PLN 51.9M | -PLN 50.4M |
| Rightofuse Assets That Do Not Meet Definition of Investment Property | PLN 450.0K | PLN 768.0K |
| Selling Expense | PLN 7.3M | PLN 6.7M |
| Share Premium | PLN 44.2M | PLN 44.2M |
Methodology
Every line item above is a fact tagged in Pharmena Spółka Akcyjna's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (PLN), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.